Efficacy of vedolizumab (VDZ) by disease localisation in Crohn's disease

被引：0
|
作者：
Allez, M. [1 ]
Braegger, F. [2 ]
Kempf, C. [2 ]
Michetti, P. [3 ,4 ]
机构：
[1] Univ Paris 07, Hop St Louis, AP HP, INSERM,UMRS 1160,Gastroenterol & Hepatol, Paris, France
[2] Takeda Pharmaceut Int AG, Zurich, Switzerland
[3] CHU Vaudois, Crohns & Colitis Ctr, Gastroenterol Source Beaulieu, Lausanne, Switzerland
[4] CHU Vaudois, Crohns & Colitis Ctr, Div Gastroenterol, Lausanne, Switzerland
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P727
引用
收藏
页码：S479 / S479
页数：1
相关论文
共 50 条
  • [31] An Assessment of Vedolizumab Immunogenicity in Perianal Crohn's Disease
    Manski, Scott
    Edirisuriya, Chelsea
    Fabrizio, Joseph
    Dioguardi, Vincent
    Shivashankar, Raina
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S848 - S848
  • [32] The safety of vedolizumab for ulcerative colitis and Crohn's disease
    Colombel, Jean-Frederic
    Sands, Bruce E.
    Rutgeerts, Paul
    Sandborn, William
    Danese, Silvio
    D'Haens, Geert
    Panaccione, Remo
    Loftus, Edward V., Jr.
    Sankoh, Serap
    Fox, Irving
    Parikh, Asit
    Milch, Catherine
    Abhyankar, Brihad
    Feagan, Brian G.
    [J]. GUT, 2017, 66 (05) : 839 - 851
  • [33] Editorial: is vedolizumab effective for perianal Crohn's disease?
    Ungar, Bella
    Kopylov, Uri
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (09) : 912 - 913
  • [34] Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
    Sandborn, William J.
    Feagan, Brian G.
    Rutgeerts, Paul
    Hanauer, Stephen
    Colombel, Jean-Frederic
    Sands, Bruce E.
    Lukas, Milan
    Fedorak, Richard N.
    Lee, Scott
    Bressler, Brian
    Fox, Irving
    Rosario, Maria
    Sankoh, Serap
    Xu, Jing
    Stephens, Kristin
    Milch, Catherine
    Parikh, Asit
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08): : 711 - 721
  • [35] CLINICAL PREDICTORS OF VEDOLIZUMAB RESPONSE IN CROHN'S DISEASE
    Saravanapavan, Hajeena
    Sebepos-Rogers, Gregory
    Fragkos, Konstantinos
    Barragry, John
    Koo, Hui Fen
    Ko, Ho Juen
    Parisi, Ioanna
    Seward, Edward
    McCartney, Sara
    Bloom, Stuart
    Mehta, Shameer
    Rahman, Farooq
    [J]. GUT, 2021, 70 : A84 - A85
  • [36] Vedolizumab for the treatment of ulcerative colitis and Crohn's disease
    McLean, Leon P.
    Shea-Donohue, Terez
    Cross, Raymond K.
    [J]. IMMUNOTHERAPY, 2012, 4 (09) : 883 - 898
  • [37] Efficacy of vedolizumab in perianal Crohn's disease: the BioLAP multi-centre observational study
    Biron, C.
    Seksik, P.
    Nachury, M.
    Nancey, S.
    Bouhnik, Y.
    Serrero, M.
    Armengol-Debeir, L.
    Buisson, A.
    Minh, M. -L. Tran
    Zallot, C.
    Fumery, M.
    Bouguen, G.
    Abitbol, V.
    Viennot, S.
    Chanteloup, E.
    Rajca, S.
    Dib, N.
    Peyrin-Biroulet, L.
    Vuitton, L.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S77 - S77
  • [38] Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2
    Feagan, Brian G.
    Schwartz, David
    Danese, Silvio
    Rubin, David T.
    Lissoos, Trevor W.
    Xu, Jing
    Lasch, Karen
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 (05): : 621 - 626
  • [39] Efficacy of vedolizumab with concomitant corticosteroid or immunomodulator use in patients with Crohn's disease in GEMINI 2
    Colombel, J. -F.
    Loftus, E. V., Jr.
    Siegel, C. A.
    Lewis, J. D.
    Smyth, M.
    Xu, J.
    Abhyankar, B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S344 - S344
  • [40] The safety and efficacy of vedolizumab for Crohn's disease and ulcerative colitis in the Hunter New England region
    Morrison, S.
    Edwards, G.
    Foster, R.
    Daley, A.
    Lawrence, O.
    Goodsall, T.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 157 - 157
12345